期刊文献+

雄激素拮抗剂氟他胺在先天性肾上腺皮质增生症治疗中应用探索 被引量:3

Pilot study on application of antiandrogen(flutamide) in the treatment of congenital adrenal hyperplasia
暂未订购
导出
摘要 为探索雄激素拮抗剂氟他胺在先天性肾上腺皮质增生症(CAH)治疗中应用价值 ,对5例经传统糖皮质激素治疗后临床控制不良的CAH患儿 ,在原糖皮质激素治疗剂量不变或减少情况下 ,加用氟他胺7.5~10mg/(kg·d)治疗6个月左右 ,以观察该新方案治疗前后临床指标及内分泌激素变化。结果显示 :氟他胺联合治疗后 ,生长速率由(10.6±2.3)cm/y减至(5.9±1.3)cm/y(P<0.05) ;血睾酮水平明显下降 ,由5.5 ,39.2(M ,Q)nmol/L降至0.2 ,9.7nmol/L(P<0.05) ;血17 -羟孕酮、脱氢表雄酮、雄稀二酮及尿17 -酮类固醇水平也均有不同程度下降。研究表明氟他胺联合较低剂量糖皮质激素治疗 ,可使CAH患儿生长速率正常化 ,改善高雄激素血症。 To evaluate the effect of antiandrogen(flutamide)on the treatment of congenital adrenal hyperplasia(CAH),five patients(4 males and 1 female) aged at 5.8±1.8 years old with 21_hydroxylase deficient CAH poorly controlled with glucocorticoid treatment were enrolled into this study.These patients were treated for six months with combination of flutamide(7.5~10 mg/kg·d) and glucocorticoid at the same or an one third reduced dosage.The results showed that the growth velocity of these patients was remarkably decelerated from 10.6±2.3 cm/y to 5.9±1.3 cm/y(P<0.05);serum testosterone levels decreased from 5.5,39.2(M,Q)nmol/L to 0.2,9.7 nmol/L(P<0.05);other androgen or its metabolites such as blood 17_hydroxyprogesterone(17_OHP),dehydroepiandrosterone(DHEA),androstenedione(A)and 24h urine 17_ketosteroid(17_KS) were also reduced in different degree after new protocol therapy,Suggesting that the normalization of growth velocity and improvement of hyperandrogenism in CAH patients could be achieved with flutamide and lower dosage of glucocorticoid combination treatment.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2003年第7期390-393,共4页 Journal of Clinical Pediatrics
关键词 雄激素拮抗剂 氟他胺 先天性肾上腺皮质增生症 治疗 应用 congenital adrenal hyperplasia 21_hydroxylase deficiency flutamide glucocorticoid androgen
  • 相关文献

参考文献11

  • 1Merke DP, Cutler GB Jr. New approaches to the treatment of congenital adrenal hyperplasia. JAMA, 1997,277(13) : 1073-1076.
  • 2Cutler GB Jr, Laue L.Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J med, 1990,323(26): 1806-1813.
  • 3Laue L, Merke DP, Jone JV, et al.A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.J Clin Endocrinol Metab,1996, 81(10) : 3535-3539.
  • 4Merke DP, Keil MF, Jones JV, et al. Flutamide, testolactone and reduced hydrocortisone does matain normal growth velocity and bone maturation despite elevated androgen level in children with congenital adrenal hyperplasia. J Clin Endocri Metab, 2000, 85(3) : 1114-1120.
  • 5Charmandari E, Johnston A, Honour JW, et al. Treatment with flutamide decreases cortisol clearance:Implications for therapy in congenital adrenal hyperplasia.J Pediatr Endocrinol Metab, 2002, 15(4) : 435- 439.
  • 6Wysowski DK, Friedman JP, Tourtelot JB, et al. Fatal and nonfatal hepatotoxicity associated with flutamide.Ann Intern Med, 1993, 118 : 860- 864.
  • 7Gomez JL, Dupont A, Cusan L, et al. Incidence of liver toxicity associated with the use of Flutamide in prostate cancer patients. Am J Med, 1992, 92 : 465- 470.
  • 8Guzman Martinez-valls PL, Ferrero Doria R, Morga Egea JP, et al. Liver failure caused by flutamide.Actas Urol Esp, 1997, 21(3) : 278- 282.
  • 9Oerter KE, Manasco P, Barnes KM, et al. Adult height in precocious puberty after long-term treatment with deslorelin. J Clin Endocri Metab, 1991, 73: 1235-1240.
  • 10Van Wyk J J, Gunther DF, Ritzen EM, et al. The use of adrenalectomy as a treatment for congenital adrenal hyperplasia.J Clin Endocrinol Metab, 1996, 81 : 3180-3189.

同被引文献18

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部